Abstract
Signal transduction mediates disease through key molecular targets in the cell. As protein‐lipid interactions have been examined in the literature, their role in cellular signaling has become more prevalent. Lipid‐binding proteins have become high impact drug targets in cancer, inflammation and viral egress. One such target, termed cytosolic phospholipase A2 α (cPLA2α), has been shown to play a key role in the production of inflammatory mediators. A novel function of the protein was recently discovered in our lab showing that the cPLA2α C2 domain bends zwitterionic membranes, a process that is mediated by cPLA2α's ability to deeply penetrate the lipid bilayer. Others in the literature have reported cPLA2α to participate in Fc mediated phagocytosis, intra‐Golgi trafficking and endosomal trafficking further supporting cPLA2α's ability to bend membranes in cellular processes. In addition, direct evidence has been reported in the literature using siRNA showing that cPLA2α induced vesiculation in cells. These results translate into our cellular system as cells transfected with EGFP‐cPLA2α form cytoplasmic vesicular structures. We have preliminary evidence showing cPLA2α membrane bending is mediated by oligomerization. The origin of oligomerization is currently under further investigation using both in vitro and cellular techniques.This research is funded by AHA 11PRE7640028 and NIH T32GM075762
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.